Acquisition of Medicines and/or Medical Supplies

• Country: Bolivia
• Summary: Acquisition of Medicines and/or Medical Supplies
• BOT Ref No: 83709466
• Deadline: 09 Jun 2023
• Financier: United Nations Secretariat
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: UNDP/BOL/COT-VIH/23/001
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Quotation are invited for Acquisition of Medicines and/or Medical Supplies NAME Acyclovir 400 mg Tablets Minimum Required Technical Characteristics Characteristics Offered DESCRIPTION Aciclovir 400 mg tablets HPAP ROW ID BOL-0349 HPMT Sheet “HIV Pharmaceutical”; Row 107 QTY. 240 Pac of 30 tablets / tablets ACCESSORIES Presentation in blister UNIT OF MEASUREMENT Pack of 30 BASIC COMPOSITION Acyclovir 400 mg MEASUREMENTS (LengthxWidthxDepth) NA FORMAT Pac of 30 tablets / tablets TECHNICAL CHARACTERISTICS - 400 mg aciclovir tablet or tablet USE Treatment of infections of the skin and mucous membranes produced by the herpes simplex virus (HSV), including sexually transmitted genital herpes; prophylaxis of infections caused by HSV in immunocompromised patients; treatment of chickenpox and herpes zoster in immunocompetent patients. DELIVERY TIME First Delivery A lot of 100 PAC x 30 Tablet maximum 15 calendar days; Minimum useful life 8 months or 75% of useful life. Second delivery - A batch of 140 PAC x 30 Tablets in a maximum of 45 calendar days, minimum shelf life 12 months Delivery times, computable from the signing of the purchase order. RELATED SERVICES: WARRANTY: For quality assurance, you must have the following documents/information: - Name and full address of the manufacturer - The Medication must have a Market Authorization (MA) granted by the Bolivian National Drug Regulatory Authority. - Medicine must be part of the National List of Essential Medicines (LINAME) - Current Sanitary Registry issued by AGEMED - Lote analysis certificate - Certificate of Good Manufacturing Practices (GMP) issued by one of the regulatory authorities of the EU, UK, USA, Australia, Canada or Japan. - Photos of the packaging and brochure of the product offered (the information reflected in them must be clearly legible). - Market Authorization (MA) number issued by one of the regulatory authorities of the EU, UK, USA, Australia, Canada or Japan, or the WHO prequalification reference number. - Letter of Authorization issued by the manufacturer and authorizing the distributor to distribute the product in Bolivia or the Certificate of Origin (indicating the product and showing the name of the manufacturer and distributor). - Certificate of Pharmaceutical Product (CPP, for its acronym in English). - Packing list or manufacturer's invoice PLACE OF DELIVERY: UNDP warehouse, La Paz Bolivia METHOD OF PAYMENT: Differentiated payments according to partial deliveries. [Disclaimer: The above text is machine translated. For accurate information kindly refer the original document.]
• Documents:

 Tender Notice